Search by Drug Name or NDC

    NDC 29978-0420-16 CapCof 2; 10; 5 mg/5mL; mg/5mL; mg/5mL Details

    CapCof 2; 10; 5 mg/5mL; mg/5mL; mg/5mL

    CapCof is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Capital Pharmaceutical, LLC. The primary component is CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 29978-0420
    Product ID 29978-420_0df9d932-80b6-9cf7-e063-6394a90a425a
    Associated GPIs 43995303141220
    GCN Sequence Number 066785
    GCN Sequence Number Description chlorpheniramine/PE/codeine LIQUID 2-5-10MG/5 ORAL
    HIC3 B3Q
    HIC3 Description OPIOID ANTITUSSIV-1ST GEN. ANTIHISTAMINE-DECONGEST
    GCN 29168
    HICL Sequence Number 037229
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/CODEINE PHOSPHATE
    Brand/Generic Brand
    Proprietary Name CapCof
    Proprietary Name Suffix n/a
    Non-Proprietary Name Codeine Phosphate, Phenylephrine Hydrochloride, Chlorpheniramine Maleate
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 2; 10; 5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Capital Pharmaceutical, LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule CV
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2025-12-31

    Package

    NDC 29978-0420-16 (29978042016)

    NDC Package Code 29978-420-16
    Billing NDC 29978042016
    Package 473 mL in 1 BOTTLE (29978-420-16)
    Marketing Start Date 2010-10-08
    NDC Exclude Flag N
    Pricing Information N/A